P. Kelly

P. Kelly, J. Djiane, G. Leblanc, 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Prolactin Activates Tyrosyl Phosphorylation of Insulin Receptor Substrate 1 and Phosphatidylinositol-3-OH Kinase*

P. Kelly, M. Edery, J. Berlanga, 1997, The Journal of Biological Chemistry.

Growth hormone, acting in part through the insulin-like growth factor axis, rescues developmental, but not metabolic, activity in the mammary gland of mice expressing a single allele of the prolactin receptor.

J. Shand, D. Flint, P. Kelly, 2002, Endocrinology.

Radioreceptor Assay for Prolactin and Other Lactogenic Hormones

P. Kelly, H. Friesen, R. Shiu, 1973, Science.

Cloning and Expression of the Rat Prolactin Receptor, a Member of the Receptor Gene Family Growth Hormone/Prolactin

P. Kelly, D. Banville, M. Edery, 1988 .

Estimation of total prolactin-binding sites after in vitro desaturation.

P. Kelly, J. Djiane, G. Leblanc, 1979, Endocrinology.

Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.

P. Kelly, J. Finidori, M. Perrot-Applanat, 1994, Endocrinology.

Immune system development and function in prolactin receptor-deficient mice.

P. Kelly, J. D. Di Santo, C. Ormandy, 1999, Journal of immunology.

Prolactin Receptor-Deficient Mice Immune System Development and Function Santo and

P. Kelly, C. Ormandy, J. P. Santo, 1999 .

Effects of progesterone and R2323 on the development of dimethylbenzanthracene-induced mammary tumors.

P. Kelly, F. Labrie, J. Raynaud, 1979, European journal of cancer.

Inhibitory effects of RU 16117, a potent estrogen antagonist, on the estrous cycle in the rat.

P. Kelly, F. Labrie, J. Raynaud, 1978, Biology of reproduction.

Androgen inhibition of basal and estrogen-stimulated prolactin binding in rat liver

P. Kelly, F. Labrie, A. Léan, 1977, Molecular and Cellular Endocrinology.

High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.

M. Caron, P. Kelly, F. Labrie, 1977, Cancer research.

Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.

P. Kelly, F. Labrie, J. Raynaud, 1976, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Prolactin receptors in the rat hypothalamus: autoradiographic localization and characterization.

P. Kelly, J. Djiane, J. Latouche, 1993, Neuroendocrinology.

Prolactin and Casein Gene Expression in the Mammary Cell

P. Kelly, L. Houdebine, J. Servely, 1983 .

Comparative localization of prolactin-binding sites in different rat tissues by immunohistochemistry, radio autography and radioreceptor assay

P. Kelly, G. Pelletier, D. Dubé, 1980, Molecular and Cellular Endocrinology.

Role of prolactin in the in vitro development of interleukin‐2‐driven anti‐tumoural lymphokine‐activated killer cells

P. Kelly, R. Foà, J. Lebrun, 1996, Immunology.

Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract.

P. Kelly, M. Nagano, C. Gespach, 1995, The American journal of physiology.

A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.

A. Ullrich, P. Kelly, S. Ali, 1995, Proceedings of the National Academy of Sciences of the United States of America.

A limited cytoplasmic region of the prolactin receptor critical for signal transduction

P. Kelly, M. Edery, J. Djiane, 1994, Molecular and Cellular Endocrinology.

Roles of extracellular and cytoplasmic domains of the prolactin receptor in signal transduction to milk protein genes.

P. Kelly, M. Edery, J. Djiane, 1993, Molecular endocrinology.

The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter.

P. Kelly, M. Edery, S. Ali, 1992, Molecular endocrinology.

Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription.

P. Kelly, M. Edery, S. Ali, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Prolactin stimulates milk protein promoter in CHO cells cotransfected with prolactin receptor cDNA

P. Kelly, M. Edery, John Clark, 1990, Molecular and Cellular Endocrinology.

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors

C. Genestie, P. Kelly, J. Kopchick, 2010, Proceedings of the National Academy of Sciences.

Mammary Gland Development

P. Kelly, M. Naylor, C. Ormandy, 2001 .

Hepatic prolactin receptors in the rat: characterization using monoclonal antireceptor antibodies.

P. Kelly, J. Djiane, M. Katoh, 1987, Endocrinology.

Identification and Characterization of Monoclonal Antibodies to Prolactin Receptors from the Mammary Gland a

P. Kelly, J. Djiane, M. Katoh, 1986, Annals of the New York Academy of Sciences.

Growth Hormone Receptor Signalling and Actions in Bone Growth

P. Kelly, J. Finidori, N. Binart, 2001, Hormone Research in Paediatrics.

The prolactin/growth hormone/cytokine receptor superfamily

P. Kelly, J. Finidori, M. Edery, 1997 .

GH Binding Protein, GH Receptors, and Domains Involved in Signal Transduction

P. Kelly, J. Finidori, M. Edery, 1995 .

Expression of two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma

P. Kelly, J. Finidori, P. Paterlini, 1994, Molecular and Cellular Endocrinology.

Growth hormone receptor structure, dimerization and function

P. Kelly, J. Finidori, M. Edery, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Regulation of Growth Hormone-Binding Protein: Clinical Implications

P. Kelly, J. Finidori, J. Léger, 1993, The Journal of pediatric endocrinology.

Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.

P. Kelly, J. Finidori, M. Edery, 1993, The Journal of clinical investigation.

Investigation of the role of prolactin in the development and function of the lacrimal and harderian glands using genetically modified mice.

P. Kelly, C. Ormandy, K. Mcclellan, 2001, Investigative ophthalmology & visual science.

Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors

P. Kelly, R. Bogorad, V. Goffin, 2008, Proceedings of the National Academy of Sciences.

A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice.

P. Kelly, N. Binart, C. Viglietta, 2003, Molecular endocrinology.

Prolactin receptor gene expression in the rabbit: Identification, characterization and tissue distribution of several prolactin receptor messenger RNAs encoding a unique precursor

P. Kelly, I. Dusanter-Fourt, J. Djiane, 1991, Molecular and Cellular Endocrinology.

Inhibitory effects of anti-prolactin receptor antibodies on prolactin binding in brain and prolactin-induced feeding behavior in ring doves.

P. Kelly, C. Li, J. Buntin, 1995, Neuroendocrinology.

Interactions between LHRH, sex steroids and inhibin in the control of LH and FSH secretion

P. Kelly, J. Drouin, F. Labrie, 1978 .

Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture.

P. Kelly, D. Blask, A. Lemus-Wilson, 1995, British Journal of Cancer.

Characterization of antisera to a partially purified prolactin receptor: effect on prolactin binding in different target tissues

P. Kelly, J. Djiane, M. Katoh, 1984, Molecular and Cellular Endocrinology.

Purification, cloning, and expression of the prolactin receptor.

P. Kelly, I. Dusanter-Fourt, M. Edery, 1989, Biology of reproduction.

Diet-induced obesity impairs mammary development and lactogenesis in murine mammary gland.

D. Flint, P. Kelly, N. Binart, 2005, American journal of physiology. Endocrinology and metabolism.

Medullary thyroid carcinoma arises in the absence of prolactin signaling.

P. Kelly, B. Caillou, L. Lacroix, 2005, Cancer research.

Primary Human Meningiomas Regulation of DNA Synthesis and Growth of Cells Derived from Updated

J. Villemure, P. Kelly, A. Weisman, 2006 .

Regulation of DNA synthesis and growth of cells derived from primary human meningiomas.

J. Villemure, P. Kelly, A. Weisman, 1986, Cancer research.

Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development.

P. Kelly, M. Freemark, A. Petryk, 1997, The Journal of clinical investigation.

Prolactin receptors and the immune system.

P. Kelly, W. Savino, M. Dardenne, 1995, Annales d'Endocrinologie.

0163-769X/05/$20.00/0 Endocrine Reviews 26(3):400–422 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/er.2004-0016 Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists

P. Kelly, V. Goffin, S. Bernichtein, 2022 .

Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants.

P. Kelly, J. Ihle, C. Carter-Su, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Prolactin receptor immunoreactivity in rat anterior pituitary.

P. Kelly, A. Ouhtit, G. Morel, 1994, Neuroendocrinology.

Intracellular transformation of prolactin following internalization into rat liver

P. Kelly, L. Houdebine, J. Djiane, 1984, Molecular and Cellular Endocrinology.

Studies of β-casein content of normal and neoplastic rat mammary tissues by a homologous radioimmunoassay

P. Kelly, M. Edery, L. Houdebine, 1984, Molecular and Cellular Endocrinology.

Absence of a putative ATP/GTP binding site in the rat prolactin receptor.

P. Kelly, M. Nagano, 1992, Biochemical and biophysical research communications.

Different forms of the prolactin receptor insights into the mechanism of prolactin action

P. Kelly, M. Edery, J. Djiane, 1992, Trends in Endocrinology & Metabolism.

Purification of prolactin receptors from sow mammary gland and polyclonal antibody production

P. Kelly, I. Dusanter-Fourt, J. Djiane, 1987, Molecular and Cellular Endocrinology.

Relative importance of the adenohypophyseal and gonadal sites in inhibitory action of LHRH agonists.

P. Kelly, F. Labrie, G. Pelletier, 1981, Biology of reproduction.

Effect of an LHRH analog on growth and hormone receptor levels in DMBA-induced mammary tumors in the rat.

P. Kelly, F. Labrie, L. Cusan, 1981, Journal of receptor research.

Further Studies on the Inhibitory Effect of [D‐A1a6, des‐Gly‐NH210]LHRH Ethylamide on Spermatogenesis and Steroidogenesis in the Rat: Reversibility and Effect of Androgen Administration

P. Kelly, F. Labrie, G. Pelletier, 1980 .

Inhibition of ovarian luteinizing hormone (LH) and follicle-stimulating hormone receptor levels with an LH-releasing hormone agonist during the estrous cycle in the rat.

P. Kelly, F. Labrie, G. Kledzik, 1978, Fertility and sterility.

Androgen regulation of prolactin‐receptor gene expression in MCF‐7 and MDA‐MB‐453 human breast cancer cells

P. Kelly, C. Clarke, R. Sutherland, 1992, International journal of cancer.

Coordinate regulation of oestrogen and prolactin receptor expression by sodium butyrate in human breast cancer cells.

P. Kelly, R. Sutherland, C. Ormandy, 1992, Biochemical and biophysical research communications.

Correlation between prolactin-receptor interaction, down-regulation of receptors, and stimulation of casein and deoxyribonucleic acid biosynthesis in rabbit mammary gland explants.

P. Kelly, L. Houdebine, J. Djiane, 1982, Endocrinology.

The Prolactin/Growth Hormone Receptor Family: Structure/Function Relationships

P. Kelly, V. Goffin, 2004, Journal of Mammary Gland Biology and Neoplasia.

Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland.

Isabelle, P. Kelly, I. Dusanter-Fourt, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of antisera to prolactin receptors.

P. Kelly, I. Dusanter-Fourt, L. Houdebine, 1985, Methods in enzymology.

Ultrastructural expression of prolactin receptor in rat liver

P. Kelly, A. Ouhtit, G. Morel, 1994, Biology of the cell.

Maintenance of prolactin (PRL) binding sites in rat liver cells in suspension culture: effect of PRL and of inhibitors of various cellular functions.

P. Kelly, L. Houdebine, J. Djiane, 1985, Endocrinology.

Interaction of prolactin (PRL) binding sites with PRL receptor antibodies in rat liver cells in suspension culture: effect of inhibitors of cellular functions.

P. Kelly, L. Ferland, A. A. Rosa, 1984, Canadian journal of physiology and pharmacology.

Prolactin-like activity of antiprolactin receptor antibodies in rat mammary tumor explants.

P. Kelly, M. Edery, L. Houdebine, 1983, Cancer research.

Prolactin receptors in explant cultures of carcinogen-induced rat mammary tumors.

P. Kelly, J. Djiane, P. Gandilhon, 1983, European Journal of Cancer and Clinical Oncology.

Stimulatory effects of prolactin and anti-prolactin receptor serum on prolactin binding sites in rat liver cells in suspension culture.

P. Kelly, L. Houdebine, J. Djiane, 1982, Biochemical and biophysical research communications.

Stimulatory effect of luteinizing hormone and human chorionic gonadotropin on testicular prolactin receptor levels.

P. Kelly, F. Labrie, C. Séguin, 1980, Biology of reproduction.

Titration of total binding sites for growth hormone in rabbit liver Quantitative modifications of these sites during pregnancy

P. Kelly, J. Djiane, P. Gérasimo, 1979, Molecular and Cellular Endocrinology.

Mechanism of action of hypothalamic hormones in the anterior pituitary gland and specific modulation of their activity by sex steroids and thyroid hormones.

M. Caron, P. Kelly, J. Drouin, 1978, Recent progress in hormone research.

Hormonal control of liver prolactin receptors.

P. Kelly, F. Labrie, A. De Léan, 1976, Current topics in molecular endocrinology.

Prolactin receptor expression in the epithelia and stroma of the rat mammary gland.

P. Kelly, F. Talamantes, J. Moffat, 2001, The Journal of endocrinology.

Expression of prolactin and its receptor in human lymphoid cells.

P. Kelly, S. Ali, J. Lebrun, 1992, Molecular endocrinology.

Prolactin receptor expression in lymphocytes from patients with hyperprolactinemia or acromegaly.

P. Kelly, M. Dardenne, M. Leite-de-Moraes, 1995, Journal of Endocrinology.

Regulation of prolactin receptor mRNA expression in peripheral lymphocytes in rats in response to changes in serum concentrations of prolactin.

P. Kelly, C. Bole-Feysot, M. Nagano, 1995, Endocrinology.

Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations.

P. Kelly, W. Savino, M. Dardenne, 1993, Journal of immunology.

Detection of in situ localization of long form prolactin receptor messenger RNA in lactating rats by biotin-labeled riboprobe.

P. Kelly, Y. Hayashi, M. Kurohmaru, 1995, Endocrine journal.

Expression of short and long forms of prolactin receptor in murine lymphoid tissues

P. Kelly, M. Dardenne, P. Touraine, 1994, Molecular and Cellular Endocrinology.

Human growth hormone-variant demonstrates a receptor binding profile distinct from that of normal pituitary growth hormone.

P. Kelly, S. Liebhaber, H. Okamura, 1990, The Journal of biological chemistry.

Mutational analysis of the ligand-binding domain of the prolactin receptor.

P. Kelly, M. Rozakis-Adcock, 1991, The Journal of biological chemistry.

Immune function of prolactin (PRL) and signal transduction by PRL/GH/cytokine receptors: specificity, redundancy and lessons from chimaeras.

P. Kelly, V. Goffin, F. Ferrag, 1997, Cytokines, cellular & molecular therapy.

Inhibitory effect of a luteinizing hormone (LH)-releasing hormone agonist on rat ovarian LH and follicle-stimulating hormone receptor levels during pregnancy.

P. Kelly, F. Labrie, G. Kledzik, 1978, Fertility and sterility.

Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.

P. Kelly, A. Schally, D. Coy, 1977, Endocrinology.

Prolactin independent rescue of mouse corpus luteum life span: identification of prolactin and luteinizing hormone target genes.

P. Kelly, P. Monget, G. Gibori, 2009, American journal of physiology. Endocrinology and metabolism.

Identification of ligand binding determinants of the prolactin receptor.

P. Kelly, M. Rozakis-Adcock, 1992, The Journal of biological chemistry.

Growth hormone (GH) induces the formation of protein complexes involving Stat5, Erk2, Shc and serine phosphorylated proteins

P. Kelly, M. Postel-Vinay, C. Kayser, 2000, Molecular and Cellular Endocrinology.

Retraction: Prolactin induces release of a factor from membranes capable of stimulating beta-casein gene transcription in isolated mammary cell nuclei.

P. Kelly, L. Houdebine, J. Djiane, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Proline-rich Sequence-mediated Jak2 Association to the Prolactin Receptor Is Required but Not Sufficient for Signal Transduction (*)

A. Ullrich, P. Kelly, S. Ali, 1995, The Journal of Biological Chemistry.

P. Kelly, F. Labrie, C. Séguin, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Caprine placental lactogen: levels of prolactin-like and growth hormone-like activities in the circulation of pregnant goats determined by radioreceptor assays.

P. Kelly, H. Friesen, G. Thorburn, 1977, The Journal of endocrinology.

Inhibition of nitric oxide synthase does not prevent the induction of long-term potentiation in vivo

R. Morris, R. Morris, P. Chapman, 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Some Consequences of Local Blockade of Nitric-Oxide Synthase in the Rat Neostriatum

G. Arbuthnott, P. Kelly, A. Wright, 1994 .

Prolactin: the new biology of an old hormone.

P. Kelly, N. Binart, V. Goffin, 2002, Annual review of physiology.

Ontogenesis of prolactin receptor gene expression in the rat olfactory system: potential roles for lactogenic hormones in olfactory development.

P. Kelly, M. Freemark, P. Driscoll, 1996, Endocrinology.

The effect of chloroquine on lysosomal prolactin receptors in rat liver.

P. Kelly, L. Houdebine, J. Djiane, 1984, Endocrinology.

Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man.

P. Kelly, F. Labrie, G. Pelletier, 1980, International journal of fertility.

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.

P. Kelly, C. Bole-Feysot, M. Edery, 1998, Endocrine reviews.

Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin

P. Kelly, F. Labrie, A. Bélanger, 1979, Molecular and Cellular Endocrinology.

Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, Des-Gly-NH210] LHRH ethylamide.

P. Kelly, F. Labrie, G. Pelletier, 1978, Endocrinology.

Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin.

P. Kelly, A. Schally, D. Coy, 1977, Biochemical and biophysical research communications.

Inhibition of Testicular and Ovarian Functions by LHRH Agonists

P. Kelly, F. Labrie, G. Pelletier, 1981 .

Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and function.

P. Kelly, F. Labrie, J. Raynaud, 1979, Advances in experimental medicine and biology.

Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice.

P. Kelly, N. Binart, A. Bachelot, 2006, Reproduction.

Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.

P. Kelly, B. Posner, H. Friesen, 1974, Endocrinology.

Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance.

J. Martial, P. Kelly, G. Bolbach, 2004, Molecular endocrinology.

Functional activity of the human prolactin receptor and its ligands

P. Kelly, H. Lochnan, M. Edery, 1995, Molecular and Cellular Endocrinology.

Immunological relationship and binding capacity of prolactin receptors in cytosolic and membrane fractions of rabbit mammary gland

P. Kelly, A. Herington, J. Djiane, 1987, Molecular and Cellular Endocrinology.

Contraception with LHRH agonists, a new physiological approach.

P. Kelly, F. Labrie, G. Pelletier, 1981, Reproduccion.

5 – SPECIFIC MODULATION OF LH-RH ACTION ON LH AND FSH SECRETION BY GONADAL STEROIDS

P. Kelly, J. Drouin, F. Labrie, 1978 .

Prostate development and carcinogenesis in prolactin receptor knockout mice.

P. Kelly, Jeffrey E. Green, M. Naylor, 2003, Endocrinology.

Differential action and secretion of rat placental lactogens.

P. Kelly, G. Gibori, L. Glaser, 1984, Endocrinology.

Lactogenic and growth hormone-like activities in pregnancy determined by radioreceptor assays.

P. Kelly, H. Friesen, R. Shiu, 1976, Endocrinology.

Characterization of rat chorionic mammotropin.

P. Kelly, H. Friesen, R. Shiu, 1975, Endocrinology.

A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D.

P. Kelly, N. Binart, V. Goffin, 2006, Molecular endocrinology.

S179D-Human PRL, a Pseudophosphorylated Human PRL Analog, Is an Agonist and Not an Antagonist.

J. Martial, P. Kelly, S. Jeay, 2001, Endocrinology.

S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist.

J. Martial, P. Kelly, S. Jeay, 2001, Endocrinology.

Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals.

J. Martial, P. Kelly, V. Goffin, 1996, Endocrine reviews.

Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.

P. Kelly, B. Demeneix, M. Edery, 2001, Endocrinology.

Cross-Talk between Signal Transducer and Activator of Transcription (Stat5) and Thyroid Hormone Receptor-β 1 (TRβ1) Signaling Pathways

P. Kelly, B. Demeneix, M. Edery, 2000 .

N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting.

P. Kelly, M. Edery, M. Perrot-Applanat, 1998, Molecular endocrinology.

Dominant negative and cooperative effects of mutant forms of prolactin receptor.

P. Kelly, M. Edery, M. Perrot-Applanat, 1997, Molecular endocrinology.

Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation.

P. Kelly, M. Edery, M. Perrot-Applanat, 1997, Journal of cell science.

Antagonistic Properties of Human Prolactin Analogs That Show Paradoxical Agonistic Activity in the Nb2 Bioassay*

J. Martial, P. Kelly, N. Binart, 1996, The Journal of Biological Chemistry.

Purification and protein sequence analysis of rat liver prolactin receptor.

P. Kelly, H. Okamura, J. Gagnon, 1989, The Journal of biological chemistry.

Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family

P. Kelly, D. Banville, I. Dusanter-Fourt, 1988, Cell.

Evolution of prolactin receptors in rabbit mammary gland during pregnancy and lactation.

P. Kelly, J. Djiane, P. Durand, 1977, Endocrinology.

Tyrosine Docking Sites of the Rat Prolactin Receptor Required for Association and Activation of Stat5*

P. Kelly, M. Edery, A. Pezet, 1997, The Journal of Biological Chemistry.

Mammary Gland Development in Prolactin Receptor Knockout Mice

P. Kelly, C. Ormandy, N. Binart, 1997, Journal of Mammary Gland Biology and Neoplasia.

Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse.

P. Kelly, N. Brousse, M. Edery, 1997, Genes & development.

Mutational analysis of the PRL receptor gene in human breast tumors with differential PRL receptor protein expression.

P. Kelly, S. Bornstein, L. Horn, 2001, The Journal of clinical endocrinology and metabolism.

Human liver growth hormone receptor and plasma binding protein: characterization and partial purification.

P. Kelly, J. Hocquette, J. Djiane, 1990, Endocrinology.

Changes of pituitary thyrotropin releasing hormone (TRH) receptor level and prolactin response to TRH during the rat estrous cycle.

P. Kelly, F. Labrie, M. Garon, 1977, Endocrinology.

Inhibition by pregnancy and lactation of steroid-induced ulcers in the rat.

P. Kelly, A. Robert, 1969, Gastroenterology.

N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.

P. Kelly, J. Djiane, P. Gandilhon, 1983, Journal of the National Cancer Institute.

Hormonal action controlling mammary activity.

P. Kelly, I. Dusanter-Fourt, L. Houdebine, 1985, Journal of dairy science.

Alteration in the receptor binding specificity of human growth hormone by genomic exon exchange.

P. Kelly, S. Liebhaber, H. Okamura, 1990, Molecular endocrinology.

Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways

P. Kelly, G. Sonenshein, S. Jeay, 2002, Molecular and Cellular Endocrinology.

Growth Hormone Exerts Antiapoptotic and Proliferative Effects through Two Different Pathways Involving Nuclear Factor-κB and Phosphatidylinositol 3-Kinase** This work was supported by INSERM, a grant from Association pour la Recherche sur le Cancer, and USPHS Grant CA-36355 from the NIH.

P. Kelly, G. Sonenshein, S. Jeay, 2001, Endocrinology.

Growth Hormone Exerts Antiapoptotic and Proliferative Effects through Two Different Pathways Involving Nuclear Factor-k B and Phosphatidylinositol 3-Kinase *

P. Kelly, G. Sonenshein, S. Jeay, 2000 .

Tail regression, apoptosis and thyroid hormone regulation of myosin heavy chain isoforms in Xenopus tadpoles

P. Kelly, L. Sachs, B. Demeneix, 1997, Molecular and Cellular Endocrinology.

Use of heterologous DNA-based gene transfer to follow physiological, T3-dependent regulation of myosin heavy chain genes in Xenopus tadpoles.

P. Kelly, L. Sachs, B. Demeneix, 1996, Endocrinology.

Endocytosis and degradation of prolactin and its receptor in Chinese hamster ovary cells stably transfected with prolactin receptor cDNA

P. Kelly, R. Salesse, M. Edery, 1994, Molecular and Cellular Endocrinology.

Increased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas

H. J. Olverman, P. Kelly, E. Paul, 2014, Biology of Mood & Anxiety Disorders.

Identification of Cytoplasmic Motifs Required for Short Prolactin Receptor Internalization*

P. Kelly, J. Mornon, V. Goffin, 1997, The Journal of Biological Chemistry.

Mouse prolactin receptor gene: genomic organization reveals alternative promoter usage and generation of isoforms via alternative 3'-exon splicing.

P. Kelly, C. Ormandy, N. Binart, 1998, DNA and cell biology.

Long and short forms of the ovine prolactin receptor: cDNA cloning and genomic analysis reveal that the two forms arise by different alternative splicing mechanisms in ruminants and in rodents.

P. Kelly, L. Schuler, C. Ormandy, 1997, Journal of molecular endocrinology.

Cloning, characterization, and tissue distribution of prolactin receptor in the sea bream (Sparus aurata).

P. Kelly, M. Edery, D. Power, 2001, General and comparative endocrinology.

Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation.

P. Kelly, W. Farrar, J. Djeu, 1992, The Journal of biological chemistry.

Characterization of prolactin receptors in pig mammary gland.

P. Kelly, P. Berthon, M. Katoh, 1984, The Biochemical journal.

P. Kelly, C. Ormandy, N. Binart, 2022 .

Temporal pattern of placental lactogen and progesterone secretion in sheep

P. Kelly, H. Friesen, H. Robertson, 1974, Nature.

Is prolactin a gonadotrophic hormone in red deer (Cervus elaphus)? Pattern of expression of the prolactin receptor gene in the testis and epididymis.

P. Kelly, M. Edery, H. Jabbour, 1998, Journal of molecular endocrinology.

Visualization of gene expression of short and long forms of prolactin receptor in rat reproductive tissues.

P. Kelly, A. Ouhtit, G. Morel, 1993, Biology of reproduction.

Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?

P. Kelly, M. Culler, V. Goffin, 2006, Nature Clinical Practice Endocrinology &Metabolism.

Prolactin and growth hormone receptors

P. Kelly, V. Goffin, 1996, Clinical endocrinology.

Benign Breast Diseases

Corinne Balleyguier, Vincent Goffin, Nadine Binart, 2005, Journal of Mammary Gland Biology and Neoplasia.

High-level expression of biologically active human prolactin from recombinant baculovirus in insect cells.

P. Kelly, J. Kopchick, V. Goffin, 2000, Protein expression and purification.

Development of Pure Prolactin Receptor Antagonists*

J. Martial, P. Kelly, J. Kopchick, 2003, Journal of Biological Chemistry.

Differential promoter usage in prolactin receptor gene expression: hepatocyte nuclear factor 4 binds to and activates the promoter preferentially active in the liver.

P. Kelly, F. Tronche, M. Nagano, 1996, Molecular endocrinology.

The effect of progestins on prolactin receptor gene transcription in human breast cancer cells.

P. Kelly, J. Graham, C. Clarke, 1992, DNA and cell biology.

Protein Phosphorylation and Protein-Protein Interactions

P. Kelly, V. Goffin, 2002 .

Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.

P. Kelly, L. Turcot-Lemay, 1980, Cancer research.

Evolution of prolactin and placental lactogen receptors in ewes during pregnancy and lactation.

P. Kelly, C. Delouis, J. Djiane, 1986, Endocrinology.

Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.

P. Kelly, F. Gouilleux, J. Finidori, 1996, Molecular endocrinology.

Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription.

P. Kelly, J. Finidori, P. Kelly, 1995, The Journal of endocrinology.

Expression cloning of a cDNA encoding a fish prolactin receptor.

P. Kelly, O. Sandra, M. Edery, 1995, Proceedings of the National Academy of Sciences of the United States of America.

The growth hormone/prolactin receptor gene family.

P. Kelly, D. Banville, M. Edery, 1991, Oxford surveys on eukaryotic genes.

Immunological recognition of the prolactin receptor: identification of a single binding unit of molecular weight ≈42 000

P. Kelly, J. Djiane, I. Dusanter-Fourth, 1987 .

Immunological recognition of the prolactin receptor: identification of a single binding unit of molecular weight approximately 42,000.

P. Kelly, I. Dusanter-Fourt, J. Djiane, 1987, Biochimie.

Differential biological activities between mono- and bivalent fragments of anti-prolactin receptor antibodies.

P. Kelly, I. Dusanter-Fourt, L. Houdebine, 1984, Endocrinology.

Prolactin receptor subtypes: a possible mode of tissue specific regulation of prolactin function.

P. Kelly, H. Jabbour, 1997, Reviews of reproduction.

Expression of the short and long forms of the prolactin receptor in murine lymphoid tissues.

P. Kelly, P. Touraine, 1995, Recent progress in hormone research.

Visualization of gene expression of short and long forms of prolactin receptor in rat digestive tissues.

P. Kelly, A. Ouhtit, G. Morel, 1994, The American journal of physiology.

Expression of the prolactin receptor gene during the breeding and non-breeding seasons in red deer (Cervus elaphus): evidence for the expression of two forms in the testis.

A. Loudon, P. Kelly, M. Edery, 1995, The Journal of endocrinology.

Receptor Domains Involved in Signal Transduction of Prolactin and Growth Hormone

P. Kelly, H. Lochnan, J. Finidori, 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of Stat 3

P. Kelly, J. Finidori, S. Moutoussamy, 1995, FEBS letters.

Monoclonal antibodies against rabbit mammary prolactin receptors. Specific antibodies to the hormone binding domain.

P. Kelly, J. Djiane, M. Katoh, 1985, The Journal of biological chemistry.

Chapter 1 Molecular aspects of prolactin and growth hormone receptors

P. Kelly, V. Goffin, F. Ferrag, 1998 .

Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors

P. Kelly, F. Labrie, J. Raynaud, 1976, Steroids.

Characterization of estrogen, progesterone and glucocorticoid receptors in rabbit mammary glands and their measurement during pregnancy and lactation.

P. Kelly, J. Djiane, R. Malancon, 1983, Journal of steroid biochemistry.

Comparative measurement of the lactogenic activity of ovine placental lactogen in rabbit and ewe mammary gland.

P. Kelly, L. Houdebine, J. Servely, 1983, General and comparative endocrinology.

Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin.

M. Caron, P. Kelly, F. Labrie, 1977, Endocrinology.

Prolactin Binding to Rat Mammary Tumor Tissue

P. Kelly, H. Friesen, J. Meites, 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Measurement by Radioimmunoassay of Casein Content in Rabbit Mammary Gland during Pregnancy and after Prolactin Stimulation in Organ Culture

P. Kelly, I. Dusanter-Fourt, L. Houdebine, 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Water-Soluble Prolactin Receptors from Porcine Mammary Gland

P. Kelly, J. Djiane, P. Berthon, 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Response to ovariectomy of N-methyl-N-nitrosourea-induced mammary tumors in the rat.

P. Kelly, L. Turcot-Lemay, 1981, Journal of the National Cancer Institute.

Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.

M. Caron, P. Kelly, F. Labrie, 1977, Journal of the National Cancer Institute.

Identification and modulation of a growth hormone-binding protein in rainbow trout (Oncorhynchus mykiss) plasma during seawater adaptation.

P. Kelly, F. Rentier-Delrue, M. Edery, 1998, General and comparative endocrinology.

Preparation and characterization of recombinant prolactin receptor extracellular domain from rat

P. Kelly, M. Nagano, J. Djiane, 1995, Molecular and Cellular Endocrinology.

Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2*

Patrick England, Vincent Goffin, Birthe B Kragelund, 2010, The Journal of Biological Chemistry.

Effects of hypophysectomy, ovariectomy, and cycloheximide on specific binding sites for lactogenic hormones in rat liver.

P. Kelly, B. Posner, H. Friesen, 1975, Endocrinology.

Identification and functional activity of prolactin receptors in thymic epithelial cells.

P. Kelly, J. Bach, W. Savino, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Identification and partial characterization of a prolactin-like hormone produced by rat decidual tissue.

P. Kelly, G. Gibori, R. Basuray, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Effect of synthetic TRH on serum prolactin, TSH and milk production in the cow.

P. Kelly, H. Friesen, R. Baker, 1973, Endocrinology.

Growth-hormone-receptor and cytokine-receptor-family signaling.

P. Kelly, J. Finidori, S. Moutoussamy, 1998, European journal of biochemistry.

Biological activities of binding site specific monoclonal antibodies to prolactin receptors of rabbit mammary gland.

P. Kelly, I. Dusanter-Fourt, J. Djiane, 1985, The Journal of biological chemistry.

In vivo study of prolactin (PRL) intracellular signalling during lactogenesis in the rat: JAK/STAT pathway is activated by PRL in the mammary gland but not in the liver.

P. Kelly, C. Bole-Feysot, J. Djiane, 1997, Biology of reproduction.

Partial proteolytic digestion of the mammary prolactin receptor: identification of smaller prolactin binding fragments.

P. Kelly, I. Dusanter-Fourt, J. Djiane, 1989, Journal of receptor research.

Defective C-Type Retrovirus Particles Secreted by Li 2i 0 Leukemia Cells1

S. Kennel, P. Kelly, D. Allison, 2006 .

DefectiveC-TypeRetrovirusParticlesSecretedby Li 2i 0 LeukemiaCells1

S. Kennel, P. Kelly, D. Allison, 1978 .

Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.

M. Low, P. Kelly, S. Hentges, 2002, The Journal of clinical investigation.

New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity

P. Kelly, S. Jeay, V. Goffin, 2003, Endocrine.

Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.

P. Kelly, J. Djiane, P. Gandilhon, 1982, Journal of the National Cancer Institute.

Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues.

P. Kelly, A. Nicolas, J. Martini, 1998, The Journal of clinical endocrinology and metabolism.

Effect of bromocriptin treatment on prolactin and steroid receptor levels in human breast cancer.

P. Kelly, J. Bonneterre, B. Hecquet, 1984, European journal of cancer & clinical oncology.

Prolactin Receptors in Human Breast Tumors

P. Kelly, L. Turcot-Lemay, 1982 .

Inhibition and Restoration of Prolactin Signal Transduction by Suppressors of Cytokine Signaling*

P. Kelly, M. Edery, Hélène Favre, 1999, The Journal of Biological Chemistry.

Dual effects of suppressor of cytokine signaling (SOCS‐2) on growth hormone signal transduction

P. Kelly, J. Finidori, M. Edery, 1999, FEBS letters.

Neuroendocrine Hormones and the Immune System

P. Kelly, G. Chrousos, J. Blalock, 1995 .

Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice.

J. Visvader, P. Kelly, M. Naylor, 2003, Recent progress in hormone research.

Structural symmetry of the extracellular domain of the Cytokine/Growth hormone/Prolactin receptor family and Interferon receptors revealed by Hydrophobic Cluster Analysis

P. Kelly, J. Mornon, E. Thoreau, 1991, FEBS letters.

Defective C-type retrovirus particles secreted by L1210 leukemia cells.

S. Kennel, P. Kelly, D. Allison, 1978, Cancer research.

Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques

P. Kelly, C. Bole-Feysot, B. Bouchard, 2000, Genome Biology.

Rational Design of Competitive Prolactin/Growth Hormone Receptor Antagonists

P. Kelly, V. Goffin, J. Jomain, 2008, Journal of Mammary Gland Biology and Neoplasia.

Development of Prolactin Receptor Antagonists: Same Goal, Different Ways

P. Kelly, V. Goffin, J. Jomain, 2007 .

Development of New Prolactin Analogs Acting as Pure Prolactin Receptor Antagonists

P. Kelly, V. Goffin, S. Bernichtein, 2003, Pituitary.

The N-terminus of human prolactin modulates its biological properties

P. Kelly, V. Goffin, J. Jomain, 2003, Molecular and Cellular Endocrinology.

Mammary gland development and the prolactin receptor.

P. Kelly, C. Ormandy, N. Binart, 2000, Advances in experimental medicine and biology.

Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.

P. Kelly, V. Goffin, F. Ferrag, 1996, Molecular endocrinology.

Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.

P. Kelly, J. Kopchick, V. Goffin, 2006, The Journal of endocrinology.

Autocrine prolactin as a promotor of mammary tumour growth

P. Kelly, V. Goffin, P. Touraine, 2005, Journal of Dairy Research.

Prolactin potentiates insulin-stimulated leptin expression and release from differentiated brown adipocytes.

P. Kelly, M. Lombès, M. Zennaro, 2004, Journal of molecular endocrinology.

The Human Growth Hormone Antagonist B2036 Does Not Interact with the Prolactin Receptor.

P. Kelly, J. Kopchick, V. Goffin, 1999, Endocrinology.

Structural and Thermodynamic Bases for the Design of Pure Prolactin Receptor Antagonists

Patrick England, Vincent Goffin, Birthe B Kragelund, 2007, Journal of Biological Chemistry.

Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation.

P. Kelly, M. Edery, F. Dif, 2003, Endocrinology.

Growth hormone receptor signalling.

P. Kelly, M. Postel-Vinay, 1996, Bailliere's clinical endocrinology and metabolism.

Immunocytochemical localization of prolactin receptors in rat liver cells: I. Dependence on sex and sex steroids

P. Kelly, O. Smirnova, O. M. Petraschuk, 1994, Molecular and Cellular Endocrinology.

Characterization of the structure and glycosylation properties of intracellular and cell surface rat hepatic prolactin receptors.

P. Kelly, B. Posner, J. Bergeron, 1992, Endocrinology.

Effects of lysosomotropic agents, cytochalasin B and colchicine on the “down-regulation” of prolactin receptors in mammary gland explants

P. Kelly, L. Houdebine, J. Djiane, 1980, Molecular and Cellular Endocrinology.

Prolactin Receptors in Organ Culture of Rabbit Mammary Gland: Effect of Cycloheximide and Prolactin

P. Kelly, Jean Djiane, Claude Delouis, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Prolactin receptor purification and biological effects of prolactin receptor antibodies.

C. Stefanis, P. Kelly, L. Houdebine, 1983 .

Intraovarian actions of GnRH.

P. Kelly, F. Labrie, G. Pelletier, 1982, Advances in experimental medicine and biology.

Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent issues in the rat

P. Kelly, F. Labrie, J. Raynaud, 1981, Molecular and Cellular Endocrinology.

LH-RH Agonists: Inhibition of Testicular Functions and Possible Clinical Applications

P. Kelly, F. Labrie, G. Pelletier, 1980 .

In vivo lactogenic effects of anti prolactin receptor antibodies in pseudopregnant rabbits.

P. Kelly, I. Dusanter-Fourt, L. Houdebine, 1983, Life sciences.

Homodimerization of IL‐2 receptor β chain is necessary and sufficient to activate Jak2 and dowstream signaling pathways

P. Kelly, B. Nelson, V. Goffin, 1998, FEBS letters.

Control of Hormone Receptor Levels and Function

P. Kelly, J. Drouin, F. Labrie, 1979 .

The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line.

P. Kelly, S. Jeay, E. Baixeras, 2001, Endocrinology.

Novel analysis for improved validity in semi-quantitative 2-deoxyglucose autoradiographic imaging

H. J. Olverman, P. Kelly, N. Dawson, 2008, Journal of Neuroscience Methods.

Prolactin-like activity of anti-prolactin receptor antibodies on casein and DNA synthesis in the mammary gland.

P. Kelly, L. Houdebine, J. Djiane, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Male reproductive function is not affected in prolactin receptor-deficient mice.

C. Pineau, P. Kelly, B. Jégou, 2003, Endocrinology.

Decysin, a New Member of the Metalloproteinase Family, Is Regulated by Prolactin and Steroids During Mouse Pregnancy1

P. Kelly, N. Binart, N. Baran, 2003, Biology of reproduction.

Characterization of a Prolactin-Regulated Gene in Reproductive Tissues Usingthe Prolactin Receptor Knockout Mouse Model1

P. Kelly, N. Binart, N. Baran, 2002, Biology of reproduction.

HYPERPROLACTINEMIE ET PATHOLOGIE OSSEUSE : VERS UNE COMPREHENSION DU ROLE DE LA PROLACTINE DANS LE METABOLISME DE L'OS

P. Kelly, P. Touraine, P. Clément-Lacroix, 1999 .

The D152H mutation found in growth hormone insensitivity syndrome impairs expression and function of human growth hormone receptor but is silent in rat receptor.

J. Wojcik, P. Kelly, J. Finidori, 1998, Journal of molecular endocrinology.

Total prolactin binding sites in human breast cancer biopsies

P. Kelly, J. Bonneterre, D. Dewailly, 2005, Breast Cancer Research and Treatment.

Rat ovarian epidermal growth factor receptors: Characterization and hormonal regulation

P. Kelly, F. Labrie, R. St-Arnaud, 1983, Molecular and Cellular Endocrinology.

Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.

P. Kelly, S. Love, P. Kehoe, 2012, American journal of translational research.

Down-Regulation of Prolactin Receptors in Rabbit Mammary Gland: Differential Subcellular Localization

P. Kelly, L. Houdebine, Jean Djiane, 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

A limited cytoplasmic region of the prolactin receptor proximal to the transmembrane domain is critical for signal transduction

P. Kelly, M. Edery, J. Djiane, 1993 .

Prolactin receptors in N-nitroso-N-methylurea-induced rat mammary tumors: relationship to tumor age and down-regulation in short-term explant culture.

P. Kelly, J. Djiane, P. Gandilhon, 1983, Anticancer research.

Prolactin receptors in human breast tumors.

P. Kelly, L. Turcot-Lemay, 1982, Journal of the National Cancer Institute.

Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids.

P. Kelly, B. Walker, J. Seckl, 2003, Endocrinology.

The Effect of Pregnancy and Lactation on Steroid-Induced Ulcers in the Rat

P. Kelly, 1968 .

Subcellular Trafficking of Growth Hormone Receptor and Jak2 under Ligand Exposure

P. Kelly, J. Finidori, S. Moulin, 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in Rats

P. Kelly, A. Blokland, J. Prickaerts, 2009, Neuropsychopharmacology.

Transcriptional regulation of prolactin receptor gene expression by sodium butyrate in MCF-7 human breast cancer cells.

P. Kelly, R. Sutherland, C. Ormandy, 1992, Endocrinology.

Immunocytochemical localization, binding, and effects of atrial natriuretic peptide in rat adipocytes

P. Kelly, L. Jeandel, J. Chabot, 1989, Molecular and Cellular Endocrinology.

Failure of Plasma Atrial Natriuretic Peptide Levels to Increase During Exercise in Patients with Chronic Atrial Fibrillation

P. Kelly, G. Kaye, P. Kelly, 1997, Pacing and clinical electrophysiology : PACE.

Effects of the 5-HT1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat

P. Grasby, P. Kelly, T. Sharp, 2005, Psychopharmacology.

Effects of the specific serotonin reuptake inhibitor, citalopram, upon local cerebral blood flow and glucose utilisation in the rat

H. J. Olverman, P. Kelly, I. Ritchie, 1999, Brain Research.

Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the dark agouti rat

H. J. Olverman, P. Kelly, I. Ritchie, 2004, Psychopharmacology.

Chronic Activation of Corticotropin-Releasing Factor Type 2 Receptors Reveals a Key Role for 5-HT1A Receptor Responsiveness in Mediating Behavioral and Serotonergic Responses to Stressful Challenge

J. Vaughan, H. J. Olverman, P. Kelly, 2012, Biological Psychiatry.

Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression

K. Lesch, P. Kelly, N. Dawson, 2011, European Neuropsychopharmacology.

Sex influences the effect of a lifelong increase in serotonin transporter function on cerebral metabolism

H. J. Olverman, P. Kelly, A. Harmar, 2009, Journal of neuroscience research.

Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the luteinizing hormone receptor persist during receptor activation.

P. Kelly, E. Milgrom, N. de Roux, 2005, Molecular endocrinology.

Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet

J. Vaughan, P. Kelly, J. Seckl, 2011, Diabetologia.

Glycyrrhetinic acid, an inhibitor of 11β-hydroxysteroid dehydrogenase, alters local cerebral glucose utilization in vivo

P. Kelly, J. Seckl, J. Sharkey, 1991, The Journal of Steroid Biochemistry and Molecular Biology.

Growth-Promoting Actions of Prolactin, the Hormone of Lactation (see paper by Bujanover et al. on p. 789)

P. Kelly, V. Goffin, 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[Growth hormone receptor. Structure and signal transduction].

P. Kelly, J. Finidori, J. Martini, 1995, Annales d'endocrinologie.

Null Mutation of the Prolactin Receptor Gene Produces a Defect in Maternal Behavior

P. Kelly, C. Ormandy, N. Binart, 1998 .

Growth hormone receptor: structure and signal transduction.

P. Kelly, J. Finidori, J. Martini, 1995, European journal of endocrinology.

Osteoblasts Are a New Target for Prolactin : Analysis of Bone Formation in Prolactin Receptor Knockout Mice *

R. Baron, P. Kelly, M. Amling, 1998 .

Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture

P. Kelly, J. Seckl, J. McCormick, 2003, Neuroscience.

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors

C. Genestie, P. Kelly, J. Kopchick, 2010, Proceedings of the National Academy of Sciences.

Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.

P. Kelly, S. Love, P. Kehoe, 2012, American journal of translational research.

Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase.

P. Kelly, G. Sonenshein, S. Jeay, 2001, Endocrinology.

P. Kelly, D. Fleenor, M. Freemark, 2001, Endocrinology.

Effect of progesterone treatment on the uptake of estradiol-17β by uterine tissues of ovariectomised rats

P. Kelly, B. Green, C. Morrison, 1978, Molecular and Cellular Endocrinology.

RU 16117, an orally active estriol-like weak estrogen.

P. Kelly, N. Faure, F. Labrie, 1984, Journal of steroid biochemistry.

Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques

P. Kelly, B. Bouchard, E. Perret, 2000, Genome Biology.

Reproductive Biology and Endocrinology Effects of Deletion of the Prolactin Receptor on Ovarian Gene Expression

P. Kelly, N. Binart, A. Bachelot, 2003 .